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Objectives: To compare the number of FoxP3+ cells between periapical granulomas (PGs) and
radicular cysts (RCs), and to correlate this number with the intensity of the inflammatory
infiltrate in these lesions and with epithelial thickness of RCs.
Study design: Thirty PGs and 30 RCs were submitted to immunohistochemical analysis using
an anti-FoxP3 polyclonal antibody. FoxP3+ cells were counted under a light microscope
(400 magnification) in five fields and the mean value was calculated for each specimen.
Statistical tests were used to evaluate differences in the number of FoxP3+ cells according to
type of lesion (PG vs. RC), intensity of the inflammatory infiltrate (grade I/II vs. grade III), and
epithelial thickness of RCs (atrophic vs. hyperplastic).
Results: FoxP3+ cells were detected in most PGs (93.3%) and RCs (93.3%). The median number
of FoxP3+ cells was 2.40 in PGs and 1.00 in RCs, with this difference being statistically
significant (P = 0.005). No significant differences in the number of FoxP3+ cells were observed
in terms of the intensity of the inflammatory infiltrate (P = 0.465) or epithelial thickness of
RCs (P = 0.737).
Conclusions: The present results suggest a greater participation of regulatory T cells in the
modulation of the inflammatory response in PGs. In addition, the presence of a less effective
regulatory environment in RCs, together with the high levels of inflammatory mediators as
reported in the literature, may contribute to the greater growth potential of these lesions.
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Periapical lesions, which include periapical granulomas (PGs)
and radicular cysts (RCs), can arise after pulp necrosis as a
consequence of the immune response to continuous antigen
stimulation by microorganisms present in the root canals.1–3
Persistent inflammation at the periapical tissues is associated
with resorption of adjacent bone, which is replaced with
fibrovascular connective tissue, forming a PG. The latter is a* Corresponding author at: Universidade Federal do Rio Grande do Nort
Patologia Oral, Av. Senador Salgado Filho, 1787 Lagoa Nova, Natal, RN,
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Open access under the Elsevier OA license.secondary and defensive reaction of the host in an attempt to
control progression of the infectious process.4 As a conse-
quence of these immunopathological responses, the epithelial
rests of Malassez are stimulated to proliferate, an event that
can result in the development of a RC.2,5
Factors such as the amount and type of cytokines, antigen
nature and the adequate expression of receptors and
costimulatory molecules, as well as the type of antigen-
presenting cells and genetic constitution of the host, modulate
the progression and severity of inflammatory processes ande, Departamento de Odontologia, Programa de Po´s-Graduac¸a˜o em
 Brazil, CEP 59056-000. Tel.: +55 84 3215 4138; fax: +55 84 3215 4138.
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helper 2 [Th2]).6,7 Although Th1/Th2 responses are induced
by cytokines, the two types of effector responses are
regulated by a heterogeneous family of cells, known as
regulatory T (Treg) cells. These cells play a major role in the
modulation of immune responses, induction and mainte-
nance of immune tolerance, and also in the prevention of
autoimmune diseases.4,8,9 The mechanism of action of Treg
cells involves direct suppression of the activation of T and B
lymphocytes and natural killer (NK) cells through cellular
mechanisms mediated by surface molecules such as
cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), or
by the synthesis of immunosuppressive cytokines such
as interleukin 10 (IL-10) and transforming growth factor
beta (TGF-b).9–13 At present, the forkhead box P3
(FoxP3) transcription factor is the best and most reliable
immunohistochemical marker for Treg cells.14–17 The basic
function of this protein is to regulate the activity of these
cells.18–20
Studies investigating the presence and function of Treg
cells in periapical lesions are scarce in the literature.
Therefore, the objective of the present study was to compare
the number of FoxP3+ cells between PGs and RCs, and to
correlate this number with the intensity of the inflammatory
infiltrate in these lesions and with epithelial thickness of RCs.
These data should contribute to a better understanding of the
immunopathogenesis and the consequent progression and
severity of periapical lesions.
2. Materials and methods
Sixty specimens, including 30 PGs and 30 RCs, obtained from
the Oral Pathology Department of the Federal University of Rio
Grande do Norte (UFRN) were randomly selected for this study.
All PGs and RCs were obtained from human teeth without
endodontic treatment. Pathological diagnoses were confirmed
on the basis of clinical, radiographic and histological criteria.
Only PGs without odontogenic epithelium were selected.
Moreover, all RCs presented unequivocal cystic cavity lined by
odontogenic epithelium. The cases were not matched for age,
gender, or anatomic location. The study was approved by the
Research Ethics Committee of UFRN, Natal, Brazil (protocol
number: 056/10).
2.1. Morphological analysis
For the morphological analysis, 5-mm-thick tissue sections
were stained with haematoxylin and eosin. The intensity of
the inflammatory infiltrate was evaluated according to an
adaptation of the method proposed by Tsai et al.21 Grading
of each specimen was recorded on the inflammatory
condition in 1 microscopic field, starting from the inner
portion of the specimen and proceeding deeper into
connective tissue. Briefly, each specimen was graded at
200 magnification as: grade I, inflammatory cells less
than one-third; grade II, inflammatory cells between one-
third and two-thirds; and grade III, inflammatory cells
more than two-thirds. Analysis of the thickness of the
epithelial lining in RCs was performed considering all thecyst lining. The thickness of the epithelial lining was defined
as atrophic (2–10 cell layers and flat epithelial/capsule
boundary) or hyperplastic (>10 cell layers and undulating
epithelial/capsule boundary, often arranged into proliferat-
ing arcades)22 based on the predominant pattern in each
case.
2.2. Immunohistochemical methods
For the immunohistochemical study, 3-mm-thick sections
were obtained from paraffin-embedded tissue blocks. The
tissue sections were deparaffinized and immersed in 3%
hydrogen peroxide to block endogenous peroxidase activity.
Antigen retrieval was performed in a Pascal pressure cooker
with citrate buffer, pH 6.0. After treatment with normal
serum, the sections were incubated with the primary anti-
FoxP3 polyclonal antibody diluted 1:150 (clone H190, Santa
Cruz Biotechnology, Santa Cruz, CA, USA) for 18 h. The
tissue sections were then washed twice in PBS and treated
with immunoperoxidase-based kit (EnVisionTM + Dual Link
System-HRP; Dako, Carpinteria, CA, USA) at room tempera-
ture to bind the primary antibody. Peroxidase activity
was visualized by immersing tissue sections in diamino-
benzidine (Liquid DAB + Substrate; Dako, Carpinteria, CA,
USA), resulting in a brown reaction product. Finally, the
tissue sections were counterstained with Mayer haematox-
ylin and coverslipped. Sections of normal human tonsil
were used as positive control for FoxP3. As negative control,
samples were treated as earlier, except that the primary
antibody was replaced by a solution of bovine serum
albumin in PBS.
2.3. Immunostaining assessment and statistical analysis
After the immunohistochemical treatment, the tissue sec-
tions were examined by two observers under a light
microscope (Olympus CX31, Olympus Japan Co., Tokyo,
Japan). Using 100 magnification, five fields with the largest
number of immunostained cells were identified. In these
fields, FoxP3+ cells were counted at 400 magnification and
the total number of positive cells per case was calculated,
permitting the calculation of the mean number of FoxP3+ cells
per specimen.
The results obtained were submitted to statistical analysis.
Computations were made using the Statistical Package for the
Social Sciences (version 17.0; SPSS Inc., Chicago, IL, USA). For
the intensity of the inflammatory infiltrate, lesions showing
inflammatory infiltrate grades I and II were combined into one
group and compared with those presenting inflammatory
infiltrate grade III. The Kolmogorov–Smirnov test revealed
absence of a normal distribution for the number of FoxP3+
cells. Therefore, to compare the number of FoxP3+ cells
according to type of lesion (PGs vs. RCs), thickness of the
epithelial lining (atrophic vs. hyperplastic), and intensity of
inflammatory infiltrate (grades I/II vs. grade III), the Mann–
Whitney non-parametric test was performed. Spearman’s
correlation test was performed to verify possible correlations
between the number of FoxP3+ cells and the intensity of the
inflammatory infiltrate. For all tests, significance level was set
at 5% (P < 0.05).
Fig. 1 – (A) Presence of FoxP3+ cells (arrows) in PG (EnVision
method, T400). (B) Photomicrograph showing FoxP3+ cells
(arrows) in RC (EnVision method, T400).
Fig. 2 – (A) Presence of FoxP3+ cells (arrows) in RC with
inflammatory infiltrate grade III (EnVision method, T400).
(B) Photomicrograph showing FoxP3+ cells (arrows) in RC
with inflammatory infiltrate grade I (EnVision method,
T400).
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3.1. Morphological analysis
Analysis of the inflammatory infiltrate in PGs revealed all
cases (n = 30; 100%) with inflammatory infiltrate grade III. In
RCs, 16 cases (53.3%) showed inflammatory infiltrate grade III,
13 cases (43.3%) inflammatory infiltrate grade II, and only 1
case (3.3%) inflammatory infiltrate grade I. Morphological
analysis of the epithelial thickness in RCs revealed the
presence of an atrophic epithelium in 25 cases (83.3%) and a
hyperplastic epithelium in only 5 cases (16.7%).
3.2. Immunohistochemical analysis
Analysis of the immunohistochemical expression of anti-
FoxP3 antibody showed the presence of FoxP3+ cells in 28 PGs
(93.3%) and in 28 RCs (93.3%). The median number of FoxP3+
cells was 2.40 (0.00–9.60) in PGs (Fig. 1A) and 1.00 (0.00–5.00) in
RCs (Fig. 1B). The non-parametric Mann–Whitney test dis-
closed a statistically significant higher median number of
FoxP3+ cells in PGs when compared to RCs (P = 0.005) (Table 1).Since no case of PG with inflammatory infiltrate grade I or II
was detected in this study, analysis of the number of FoxP3+
cells according to intensity of the inflammatory infiltrate was
performed only in RCs. The median number of FoxP3+ cells
was 1.20 (0.00–5.00) in lesions with inflammatory infiltrate
grade III (Fig. 2A) and 1.00 (0.20–4.40) in lesions with
inflammatory infiltrate grade I/II (Fig. 2B). Comparison of
the median number of FoxP3+ cells in relation to the intensity
of the inflammatory infiltrate revealed no statistically signifi-
cant difference between groups (P = 0.465) (Table 1). In
addition, Spearman’s correlation test disclosed no significant
correlation between the number of FoxP3+ cells and the
intensity of the inflammatory infiltrate (r = 0.090; P = 0.635).
With respect to the thickness of the epithelial lining, the
median number of FoxP3+ cells was 1.40 (0.20–2.80) in lesions
with hyperplastic epithelium and 1.00 (0.00–5.00) in lesions
with atrophic epithelium. The non-parametric Mann–Whitney
test revealed no statistically significant differences in the
median number of FoxP3+ cells between RCs with atrophic
Table 1 – Median number of FoxP3+ cells in periapical granulomas and radicular cysts, and their differences in relation to
type of lesion, grade of inflammatory infiltrate and epithelial thickness.
Variable n Median Q25–Q75 Mean of ranks Sum of ranks U P
Lesion
Periapical granuloma 30 2.40 1.55–5.05 36.85 1105.50 259.50 0.005
Radicular cyst 30 1.00 0.55–2.80 24.15 724.50
Inflammatory infiltrate
Grade I/II 14 1.00 0.60–3.05 16.75 234.50 94.50 0.465
Grade III 16 1.20 0.25–2.35 14.41 230.50
Epithelial thickness
Atrophic 25 1.00 0.60–2.90 15.74 393.50 56.50 0.737
Hyperplastic 5 1.40 0.20–2.60 14.30 71.50
a r c h i v e s o f o r a l b i o l o g y 5 7 ( 2 0 1 2 ) 1 1 5 9 – 1 1 6 41162epithelium and RCs with hyperplastic epithelium (P = 0.737)
(Table 1).
4. Discussion
Periapical lesions develop in response to chronic antigenic
stimulation of periapical tissue caused by bacterial infection
in root canal.13 As a consequence, innate and acquired
defence mechanisms are activated, which comprise vascular
and cellular events that culminate in alveolar bone resorp-
tion in the apex of the tooth.23 Different cells are involved in
this process, including neutrophils, macrophages, NK cells,
Langerhans cells, and T and B lymphocytes, as well as Treg
cells which regulate the immune response.3,24 However, the
role of Treg cells in the modulation of the immune response
in PGs and RCs has not been fully established.9,13,19
According to Salomon et al.25 a combination of strong
antigen signals and maximum costimulation is necessary
for the development of Treg cells. This condition is easily
found in periapical lesions due to the strong antigen
stimulation arising from the root canals,1,5,9,13,19 a fact
explaining the presence of FoxP3+ cells in most PG (93.3%)
and RC (93.3%) specimens studied here.
The present immunohistochemical study evaluated the
number of FoxP3+ cells in PGs and RCs. The results showed a
significantly larger number of FoxP3+ cells in PGs compared to
RCs (P = 0.005). Similarly, Fukada et al.9 investigating the
mRNA expression of FoxP3 and of cytokines involved in Th1
(T-bet, interferon-g [IFN-g]) and Th2 (GATA-3, IL-4, IL-10)
responses by real time-PCR in RCs and PGs, observed higher
expression of FoxP3 and IL-10 in the latter. According to these
authors, Treg cells play an important role in the modulation of
the inflammatory microenvironment of periapical lesions.
The authors suggested a possible suppression of the Th1
response in PGs. On the other hand, Marc¸al et al.3 evaluating
the number of FoxP3+ cells in RCs and PGs, found no significant
differences between these lesions.
Proinflammatory cytokines such as IFN-g and tumour
necrosis factor alpha (TNF-a) regulate Th1 responses, whereas
IL-4 is the key cytokine involved in Th2 responses. These
mediators trigger inflammatory responses that result in the
progression of periapical lesions.3,23,26 These immune
responses are modulated by FoxP3+ cells through direct
cellular mechanisms, mediated by CTLA-4,7,11,18,27 or through
indirect mechanisms, mediated by the synthesis of TGF-b and
IL-10.4,7,9,13,27,28 In a comparative study of PGs and RCs,Teixeira-Salum et al.4 detected higher expression of TGF-b
in PGs, and of IL-4, IFN-g and TNF-a in RCs. Taken together, the
results reported by these authors and the present findings
suggest a more effective participation of FoxP3+ cells in the
modulation of inflammatory responses in PGs, which can be
explained by the high expression of TGF-b, a molecule
suppressing Th1 and Th2 responses, and by the low levels
of proinflammatory mediators regulating Th1 (IFN-g and TNF-
a) and Th2 (IL-4) responses in these lesions. Also within this
context, the smaller number of FoxP3+ cells in RCs in
comparison with PGs, observed in the present study, together
with the high levels of inflammatory mediators and low levels
of TGF-b in these lesions reported in other studies,3,4 may be
related to the existence of a minimal regulatory environment
in RCs that may contribute to the greater growth potential of
these lesions.2,29–31
FoxP3+ cells have been studied in diseases of different
aetiology, such as rheumatoid arthritis,32 atopic dermatitis,33
lichen planus,34 and intestinal inflammatory disease.35 In an
animal model of experimental periodontitis, Garlet et al.27
observed increased levels of Treg cells and high expression of
immunosuppressive cytokines (CTLA-4, TGF-b, and IL-10). The
authors also found that animals treated with anti-glucocorti-
coid-inducible TNF receptor (GITR), an inhibitor of Treg cell
function, exhibited a marked increase in bone loss and
inflammatory cell migration, as well as a decrease in the
expression of immunosuppressive cytokines. In agreement
with these findings, Nakajima et al.8 suggested that in
gingivitis Treg cells control the immunopathological process
by preventing the destruction of periodontal bone. On the
other hand, in established periodontitis Treg cells are
recruited to suppress bone destruction through putative
autoimmune mechanisms via a negative feedback system.8
It has been suggested that the higher the intensity of the
inflammatory infiltrate, the higher the antigen stimulation
and consequent tissue damage.36 On the other hand, immune
surveillance by Treg cells would limit the tissue damage
provoked by the host immune response and by the direct
action of the microorganisms.27,37 Despite those reports, in the
present study, no significant difference in the number of
FoxP3+ cells was observed in terms of the intensity of the
inflammatory infiltrate of RCs (P = 0.465). In addition, no
significant correlation was found between the number of
FoxP3+ cells and the intensity of the inflammatory infiltrate
(P = 0.635). Thus, immune surveillance by Treg cells does not
seem to be more effective in RCs with intense inflammatory
infiltrates.
a r c h i v e s o f o r a l b i o l o g y 5 7 ( 2 0 1 2 ) 1 1 5 9 – 1 1 6 4 1163The status of the lining epithelium (atrophic or hyper-
plastic) has been described as a histological parameter
indicating growth activity/inactivity in RCs.22 In quiescent
lesions (atrophic epithelium), no cystic growth is observed
despite the presence of antigens and enzymes able to induce
immune responses, epithelial proliferation, and bone resorp-
tion.22 During this phase, the growth of RCs is probably limited
by immunosuppressive responses.22 Nevertheless, no signifi-
cant difference in the number of FoxP3+ cells was observed
between RCs with hyperplastic and atrophic epithelium
(P = 0.735). In view of the small number of RCs with
hyperplastic epithelium (n = 5) in the present study, further
investigations are needed to identify possible differences in
the immune response between active (hyperplastic epitheli-
um) and quiescent (atrophic epithelium) RCs.
In conclusion, the present results demonstrated the
presence of FoxP3+ cells in inflammatory periapical lesions
and a larger number of these cells in PGs compared to RCs,
suggesting a greater participation of Treg cells in the
modulation of the inflammatory response in the former. In
addition, the number of FoxP3+ cells was not intimately
correlated with the intensity of the inflammatory infiltrate or
with the thickness of the lining epithelium in RCs. It is
suggested that the presence of a less effective regulatory
environment in RCs, associated with high levels of inflamma-
tory mediators as reported in the literature, contribute to the
greater growth potential of these lesions.
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